Marker Therapeutics (MRKR) FCF Margin (2016 - 2025)
Marker Therapeutics (MRKR) reported FCF Margin of 172.2% for Q4 2025, up 3667.0% year-over-year from 4.57% in Q4 2024, and up 22.4% quarter-over-quarter from 221.9% in Q3 2025.
Marker Therapeutics (MRKR) FCF Margin (2016 - 2025) Analysis & Trends
Marker Therapeutics (MRKR) has 9 years of FCF Margin data on file, last reported at 172.2% in Q4 2025.
- FCF Margin for Q4 2025 came in at 172.2%, up 3667.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 338.74% (down 19174.0% YoY), and the FY2025 annual result was 338.74%, down 17321.0% from the prior year.
- FCF Margin improved to 172.2% in Q4 2025 per MRKR's latest filing, from 221.9% in the prior quarter.
- Over five years, FCF Margin peaked at 1957.58% in Q2 2023 and troughed at 1575.39% in Q1 2025.
- A 4-year average of 179.99% and a median of 213.49% in 2024 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2023 and 2024: FCF Margin soared 243687 bps in 2023, then slumped 213596 bps in 2024.
- A 4-year view of FCF Margin shows it stood at 1256.37% in 2022, then jumped by 37 bps to 795.39% in 2023, then surged by 74 bps to 208.86% in 2024, then advanced by 18 bps to 172.2% in 2025.
- Business Quant data shows MRKR's FCF Margin at 172.2% in Q4 2025, 221.9% in Q3 2025, and 218.11% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -3.98% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Marker Therapeutics | 28.20 Mn | 28.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -172.20% |
| Sep 30, 2025 | -221.90% |
| Jun 30, 2025 | -218.11% |
| Mar 31, 2025 | -1,575.39% |
| Dec 31, 2024 | -208.86% |
| Sep 30, 2024 | 62.17% |
| Jun 30, 2024 | -178.38% |
| Mar 31, 2024 | -308.43% |
| Dec 31, 2023 | -795.39% |
| Sep 30, 2023 | 1,905.43% |
| Jun 30, 2023 | 1,957.58% |
| Mar 31, 2023 | -129.61% |
| Dec 31, 2022 | -1,256.37% |
| Sep 30, 2022 | -531.44% |
| Jun 30, 2022 | 300.39% |
| Mar 31, 2022 | -1,509.31% |
| Jun 30, 2020 | -1,463.56% |
| Dec 31, 2019 | -2,280.43% |
| Jun 30, 2018 | -1,164.70% |
| Sep 30, 2017 | -1,106.36% |